Cargando…
Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease
Alzheimer’s disease is a neurodegenerative disorder associated with age, and is characterized by pathological markers such as amyloid-beta plaques and neurofibrillary tangles. Symptoms of AD include cognitive impairments, anxiety and depression. It has also been shown that individuals with AD have i...
Autores principales: | Roy, Jaydeep, Tsui, Ka Chun, Ng, Jonah, Fung, Man-Lung, Lim, Lee Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268832/ https://www.ncbi.nlm.nih.gov/pubmed/34202125 http://dx.doi.org/10.3390/ijms22136841 |
Ejemplares similares
-
Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer’s Disease
por: Wong, Kan Yin, et al.
Publicado: (2020) -
Therapeutic Potential of Human Stem Cell Implantation in Alzheimer’s Disease
por: Chan, Hau Jun, et al.
Publicado: (2021) -
Distribution and inter-regional relationship of amyloid-beta plaque deposition in a 5xFAD mouse model of Alzheimer’s disease
por: Tsui, Ka Chun, et al.
Publicado: (2022) -
Implications of GABAergic Neurotransmission in Alzheimer’s Disease
por: Li, Yanfang, et al.
Publicado: (2016) -
Melatonin in Alzheimer’s Disease
por: Lin, Li, et al.
Publicado: (2013)